10class.wk11 - PubH 7420 Clinical Trials Readings for Week...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
PubH 7420 Clinical Trials: Readings for Week 11 1. Friedman, Furberg, and DeMets. Fundamentals of Clinical Trials , Chapter 15. Supplemental Reading/References 1. Pocock, SJ.: Clinical Trials: A Practical Approach. John Wiley and Sons, Ltd., Chapters 14. 2. DeMets D, Fleming T, et al. The Data and Safety Monitoring Board and Acquired Immune Deficiency Syndrome (AIDS) Clinical Trials. Cont. Clinical Trials , 16:408-421, 1995. 3. Task Force of the Working Group on Arrhythmias of the European Society of Caridiology. The early termination of clinical trials: causes, consequences, and control. Circulation 89:2892-2907, 1994. 4. Meinert C. Clinical tirals and treatment effects monitoring (with comment). Cont. Clinical Trials , 19:515-543, 1998. 5. Guidance for clinical trial sponsors on the establishment and operation of clinical trial data monitoring committees ( www.fda.gov/cber/gdlns/clindatmon.htm ) 6. Ellenberg SS, Fleming TR, DeMets DL. Data monitoring committees in clinical trials. A practical perspective. 7. DeMets D, Califf R, et al. Issues in regulatory guidelines for data monitoring committee. Clinical Trials 1:162-169, 2004. 8. McPherson K. Statistics: the problem of examining accumulating data more than once. NEJM 290:501-502, 1974. 9. Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. 10. Fleming TR, Neaton JD, et al. Insights from monitoring the CPCRA didanosine/zalciabine trial. JAIDS 10:S9-S18, 1995. 11. DeMets DL, Furberg CD, Friedman LM. Data monitoring in clinical trials. A case studies approach. Springer, 2006. 1
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Considerations for Sequential Monitoring of Clinical Trials with Fixed Sample Sizes for Adverse Effects and Therapeutic Benefit 1. Most clinical trials are designed with a fixed sample size (or expected number of events for morbidity and mortality studies). This is in contrast to sequential designs in which the sample size is not fixed by design but depends on the
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 11/21/2011 for the course PUBH 7420 taught by Professor Ph7420 during the Spring '07 term at Minnesota.

Page1 / 4

10class.wk11 - PubH 7420 Clinical Trials Readings for Week...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online